University of Cincinnati Adds Master s Program in Clinical and Translational Research
The program was approved by the UC Board of Trustees in September and is currently under review by the Ohio Board of Regents.
For the past 20 years, the medical community has become increasingly concerned about the reluctance of young physicians to seek additional training and pursue clinical research, says Erin Haynes, DrPH, an epidemiologist with UCs environmental health department and the programs director. We have fewer physicians pursuing careers in clinical research and an unacceptably high attrition rate for accomplished clinical investigators currently practicing.
The Association of American Medical Colleges says there is an urgent need for medical schools and teaching hospitals to create new models for clinical research training and provide a nurturing environment in which the next generation of physician-scientists can conduct high-quality research.
Haynes says the UC masters program was designed to give students in-depth training in epidemiology, study design, biostatistics, ethical issues and many other areas related to helping physician-scientists master the challenges of conducting clinical research in the next decade.
Our masters program fills a void in training that physicians are asking forand needto be effective clinical investigators who make smart decisions when conducting clinical research, adds Joel Tsevat, MD, MPH, a UC professor of medicine and director of outcomes research for the internal medicine department.
Formally developed in 2004, the new masters in clinical and translational research builds on existing courses offered through the UC Department of Environmental Health. This includes four specialty areas or tracks led by experts in the
University officials say the 48 credit hour masters program can be completed on a part-time basis in two years and currently has 41 students enrolled: 39 physicians and two pharmacists. It is offered through UCs environmental health department and is one of only three masters level courses of this kind in
Under Tsevats leadership, UC applied for a K30 clinical research curriculum award from the National Institutes of Health (NIH). In August 2005, UC received a $1.5 million NIH grant that enabled it to add the necessary coursework to complete the masters level curriculum.
Physicians, nurses, pharmacists and other health professionals interested in pursuing evidence-based clinical research are eligible to apply to the masters program.
Curriculum topics include: clinical epidemiology, translational research, clinical effectiveness, biostatistics, clinical research informatics, molecular epidemiology and clinical trials. Upon completion of the program, graduates should be able to develop research hypotheses, specific criteria and methodology for conducting patient-oriented research and understand how to apply contemporary research tools to these clinically relevant areas of investigation.
The UC curriculum includes a combination of instructional coursework, seminars and individual mentoring sessions designed to foster both the analytic and quantitative skills necessary for conducting research. Students must also complete a thesis based upon their own independent clinical, laboratory or field research.
What I love about this program is that it is designed to respect the time constraints of full-time clinicians, says Emily DeFranco, DO, an obstetrician-gynecologist who began participating in the program this summer. Im able to pursue my scientific endeavors and education without compromising my clinical or family obligations.
Many of my mentors were trained in epidemiology and biostatistics. I was in awe of the tools they had at their disposal because it allowed them to be truly independent researchers, she adds.
That was something I quickly sought to emulate, but I also recognized my deficiencies. My base knowledge is sound, but I have a lot to learn when it comes to advanced analytic methods and complex study designs.
For more information on the masters of clinical and translational research, visit www.eh.uc.edu/clinicalresearch.
Joel Tsevat, MD, professor of general internal medicine
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.